Evidence map›Paper›PMID 40898875›Full record

ArticleBrain : a journal of neurology2026

Repeat-associated ataxias in a German patient cohort analysed by targeted parallel long-read sequencing.

Hannes Erdmann, Annalisa Schaub, Morghan C Lucas, Veronika Scholz, Anna Benet-Pagès, Kerstin Becker, Christine Dineiger, Veronika Mayer, Inga van Buren, Eva Breithausen and 43 more

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Frequency of ZFHX3-Mediated Spinocerebellar Ataxia 4 in a US Undiagnosed Ataxia Cohort.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

53 authors.

Hannes ErdmannMedical Genetics Center (MGZ) Munich, 80335 Munich, Germany.ORCID 0000-0002-2620-1850
Annalisa SchaubMedical Genetics Center (MGZ) Munich, 80335 Munich, Germany.
Morghan C LucasMedical Genetics Center (MGZ) Munich, 80335 Munich, Germany.ORCID 0000-0001-7654-9137
Veronika ScholzMedical Genetics Center (MGZ) Munich, 80335 Munich, Germany.
Anna Benet-PagèsMedical Genetics Center (MGZ) Munich, 80335 Munich, Germany.
Kerstin BeckerMedical Genetics Center (MGZ) Munich, 80335 Munich, Germany.
Christine DineigerMedical Genetics Center (MGZ) Munich, 80335 Munich, Germany.
Veronika MayerMedical Genetics Center (MGZ) Munich, 80335 Munich, Germany.
Inga van BurenMedical Genetics Center (MGZ) Munich, 80335 Munich, Germany.
Eva BreithausenMedical Genetics Center (MGZ) Munich, 80335 Munich, Germany.
Karl AkbariSchool of International Business, Hochschule Bremen, 28199 Bremen, Germany.
Isabell CordtsDepartment of Neurology, Department of Neurology, Klinikum Rechts der Isar, Technical University of Munich, 81675 Munich, Germany.ORCID 0000-0002-2078-1997
Mayra SauerMedical Genetics Center (MGZ) Munich, 80335 Munich, Germany.
Christine SchneiderDepartment of Neurology, University Medical Center Augsburg, 86156 Augsburg, Germany.
Rosanna KrakowskyInstitute of Human Genetics, University of Leipzig Medical Center, 04103 Leipzig, Germany.
Franziska SchnabelInstitute of Human Genetics, University of Leipzig Medical Center, 04103 Leipzig, Germany.
Konstanze DunkerGerman Center for Vertigo and Balance Disorders, LMU University Hospital, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
Lena FabritiusGerman Center for Vertigo and Balance Disorders, LMU University Hospital, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
Johannes GerbGerman Center for Vertigo and Balance Disorders, LMU University Hospital, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.ORCID 0000-0002-5053-1462
Denis GrabovaGerman Center for Vertigo and Balance Disorders, LMU University Hospital, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
Ken MöhwaldGerman Center for Vertigo and Balance Disorders, LMU University Hospital, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
Marius NäherGerman Center for Vertigo and Balance Disorders, LMU University Hospital, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
Karoline SteinmetzGerman Center for Vertigo and Balance Disorders, LMU University Hospital, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
Franziska ThiessenGerman Center for Vertigo and Balance Disorders, LMU University Hospital, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
Alexander JäckDepartment of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
Christiane Schneider-GoldDepartment of Neurology, St Josef Hospital, Ruhr-University of Bochum, 44791 Bochum, Germany.
Simone ZittelDepartment of Neurology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Christina PetersenPraxis für Humangenetik, Zentrum für Ambulante Medizin, Institute of Human Genetics, University of Jena, 07743 Jena, Germany.
Isolde SchreyerPraxis für Humangenetik, Zentrum für Ambulante Medizin, Institute of Human Genetics, University of Jena, 07743 Jena, Germany.
Larissa MämeckeMitteldeutscher Praxisverbund Humangenetik, 06110 Halle/Saale, Germany.
Sibylle WilflingCenter for Human Genetics Regensburg, 93047 Regensburg, Germany.
Gilbert WunderlichDepartment of Neurology and Center for Rare Diseases, Faculty of Medicine and University Hospital, University of Cologne, 50937 Cologne, Germany.
David BrennerDepartment of Neurology, Ulm University, 89081 Ulm, Germany.ORCID 0000-0002-1535-3146
Yorck HellenbroichInstitute of Human Genetics, University Hospital Schleswig-Holstein, University of Luebeck and Kiel, 23538 Luebeck, Germany.
Kirsten MuhleDepartment of Neurology, University Hospital Münster, 48149 Münster, Germany.
Tessa HuchtemannDepartment of Neurology, University Hospital Münster, 48149 Münster, Germany.
Inga ClausDepartment of Neurology, University Hospital Münster, 48149 Münster, Germany.
Thomas KlopstockFriedrich Baur Institute at the Department of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität München, 80336 Munich, Germany.
Michael StruppDepartment of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
Johannes LevinDepartment of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.ORCID 0000-0001-5092-4306
Günter U HöglingerDepartment of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
Doreen HuppertGerman Center for Vertigo and Balance Disorders, LMU University Hospital, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
Sandra Becker-BenseGerman Center for Vertigo and Balance Disorders, LMU University Hospital, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
Filipp FilippopulosGerman Center for Vertigo and Balance Disorders, LMU University Hospital, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
Fabian KilpertInstitute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.ORCID 0000-0001-6401-2180
Elsa LeitãoInstitute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.
Sabine KayaInstitute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.
Christel DepienneInstitute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.ORCID 0000-0002-7212-9554
Florian SchöberlDepartment of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
Teresa NeuhannMedical Genetics Center (MGZ) Munich, 80335 Munich, Germany.
Elke Holinski-FederMedical Genetics Center (MGZ) Munich, 80335 Munich, Germany.
Andreas ZwergalGerman Center for Vertigo and Balance Disorders, LMU University Hospital, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.ORCID 0000-0002-3839-8398
Angela AbichtMedical Genetics Center (MGZ) Munich, 80335 Munich, Germany.

Funding

Federal Ministry of Research and Education
6 · The paper itself

Abstract

Hereditary adult-onset ataxias are a heterogeneous group of phenotypically overlapping conditions, often caused by pathogenic expansions of short tandem repeats. Currently, 18 repeat disorders with a core phenotype of adult-onset ataxia are known. Diagnosis typically relies on sequential PCR-based methods, which are labour-intensive and lack precision. Long-read sequencing (LRS) has the potential to overcome these limitations and is currently implemented and validated in clinical genetics. Using clinical nanopore Cas9-targeted sequencing (Clin-CATS) for parallel in-depth repeat analysis, we evaluated a diagnostic cohort of 513 adult-onset ataxia patients, determining frequencies of all known repeat-associated ataxias except Spinocerebellar ataxia 4 (SCA4), as well as the carrier frequencies for autosomal-recessive disorders, RFC1 spectrum disorder and Friedreich's ataxia (FRDA). Additionally, phenotypes of patients with established genetic diagnoses were characterized, especially those of patients living with RFC1 spectrum disorder and SCA27B. Repeat-associated ataxias were confirmed in 33.3% of cases, including rare ataxias, such as SCA10, SCA36 and SCA37, alongside as the most prevalent conditions SCA27B and RFC1 spectrum disorder. Potentially pathogenic expansions in FGF14 were identified in an additional 4.7% of patients. Testing of another 347 patients for ZFHX3 expansions linked to SCA4 did not identify any cases. Dual diagnoses were frequent, occurring in 6.4% of patients with repeat-associated ataxia. We confirmed a high RFC1 spectrum disorder carrier frequency (7.2%) and reclassified certain FXN expansions as likely non-pathogenic, resulting in a lower than estimated carrier frequency for FRDA of 0.8%. We also identified novel repeat configurations in several loci and illustrated the high heterogeneity of repeat expansions in RFC1, highlighting it as a potential source of false results when using PCR-based methods. This study underscores the diagnostic advantages of LRS for comprehensive repeat analysis and recommends its adoption as a standard in clinical genetics, replacing Southern blot and PCR-based approaches. Furthermore, based on our findings in a large patient cohort a re-evaluation of existing phenotype-genotype correlations is recommended as well as evaluating additional parameters alongside the repeat length to improve diagnostic precision of repeat analysis.

Indexed as

AtaxiaAdultAgedCohort StudiesDNA Repeat ExpansionFemaleFriedreich AtaxiaGermanyHumansMaleMiddle AgedPhenotypeReplication Protein CYoung AdultReplication Protein CRFC1 protein, humanhereditary ataxialong-read sequencingOxford Nanoporerepeat analysisrepeat expansion disordersRFC1

Identifiers

PMID40898875
PMCPMC13017427

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.